Assembly biosciences appoints nicole s. white, phd, as senior vice president of pharmaceutical development and manufacturing

South san francisco, calif., nov. 17, 2020 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis b virus (hbv) and diseases associated with the microbiome, today announced the appointment of nicole s. white, phd, as senior vice president of pharmaceutical development and manufacturing. dr. white brings over 20 years of experience overseeing the complexities of the chemistry manufacturing and controls process.
ASMB Ratings Summary
ASMB Quant Ranking